+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Neurologic Disorders Therapeutics Market Size, Share, and COVID-19 Impact Analysis by Segmentation, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Mar 2024
Report ID:HC-1125
Base Year:2023
Report Format:PDF, Excel
Report Pages:186
Region:Global

Table of Content

  1. Global Neurologic Disorders Therapeutics Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Neurologic Disorders Therapeutics Market Scope and Market Estimation
      1. Global Neurologic Disorders Therapeutics Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
      2. Global Neurologic Disorders Therapeutics Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
    3. Market Segmentation
      1. Type of Global Neurologic Disorders Therapeutics Market
      2. Application of Global Neurologic Disorders Therapeutics Market
      3. Region of Global Neurologic Disorders Therapeutics Market
  2. Global Neurologic Disorders Therapeutics Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets
      3. Market Attractiveness Analysis
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Neurologic Disorders Therapeutics Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Neurologic Disorders Therapeutics Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Type
      2. By Application
  4. Global Neurologic Disorders Therapeutics Market: Estimates & Historic Trend Analysis (2017-2020)
  5. Global Neurologic Disorders Therapeutics Market Estimates & Forecast Trend Analysis, by Type
    1. Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, by Type, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurologic Disorders Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Type, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Central Nervous System (CNS)
    4. Peripheral Nervous System (PNS)
  6. Global Neurologic Disorders Therapeutics Market Estimates & Forecast Trend Analysis, by Application
    1. Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, by Application, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurologic Disorders Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Paralysis
    4. Muscle Weakness
    5. Poor Coordination
    6. Loss of Sensation
    7. Seizures
    8. Confusion
    9. Pain and Altered Levels of Consciousness
  7. Global Neurologic Disorders Therapeutics Market Analysis and Forecast, by Region
    1. Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Neurologic Disorders Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  8. North America Neurologic Disorders Therapeutics Market: Estimates & Forecast Trend Analysis
    1. North America Market Assessments & Key Findings
    2. North America Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. North America Neurologic Disorders Therapeutics Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. U.S.
        2. Canada
        3. Mexico
  9. Europe Neurologic Disorders Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Europe Market Assessments & Key Findings
    2. Europe Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Europe Neurologic Disorders Therapeutics Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  10. Asia Pacific Neurologic Disorders Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Asia Pacific Market Assessments & Key Findings
    2. Asia Pacific Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  11. Middle East & Africa Neurologic Disorders Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Middle East & Africa Market Assessments & Key Findings
    2. Middle East & Africa Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East & Africa
  12. South America Neurologic Disorders Therapeutics Market: Estimates & Forecast Trend Analysis
    1. South America Market Assessments & Key Findings
    2. South America Neurologic Disorders Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  13. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Neurologic Disorders Therapeutics
    3. Manufacturing Process Analysis of Neurologic Disorders Therapeutics
    4. Industry Chain Structure of Neurologic Disorders Therapeutics
  14. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Neurologic Disorders Therapeutics Distributors
    3. Neurologic Disorders Therapeutics Customer
  15. Competition Landscape
    1. Key Manufacturers Neurologic Disorders Therapeutics Producing Area Distribution, Sales Area, Type
    2. Key Manufacturers Neurologic Disorders Therapeutics Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  16. Company Profiles
    1. AbbVie Inc
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    2. Acadia Pharmaceuticals Inc.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    3. Acorda Therapeutics Inc.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    4. Bayer AG
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    5. Biogen Inc.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    6. Eisai Co. Ltd.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    7. F. Hoffmann La Roche Ltd.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    8. GlaxoSmithKline Plc
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    9. H Lundbeck AS
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    10. Johnson and Johnson
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    11. Merck KGaA
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    12. Mylan NV
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    13. Novartis AG
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    14. Otsuka Holdings Co. Ltd.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    15. Pfizer Inc.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    16. Sanofi
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    17. Takeda Pharmaceutical Co. Ltd.
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    18. Teva Pharmaceutical Industries Ltd
      1. Company Information
      2. Neurologic Disorders Therapeutics Product Offered
      3. Neurologic Disorders Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
  17. Assumptions and Research Methodology
  18. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion

List of Tables

  1. Global Neurologic Disorders Therapeutics Market Historic Analysis (US$ Mn), 2017-2021
  2. Global Neurologic Disorders Therapeutics Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
  3. Global Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  4. Global Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  5. Global Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  6. Global Neurologic Disorders Therapeutics Market Analysis by Region, 2017-2030
  7. North America Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  8. North America Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  9. North America Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  10. North America Neurologic Disorders Therapeutics Market Analysis by Country, 2017-2030
  11. South America Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  12. South America Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  13. South America Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  14. South America Neurologic Disorders Therapeutics Market Analysis by Country, 2017-2030
  15. Europe Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  16. Europe Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  17. Europe Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  18. Europe Neurologic Disorders Therapeutics Market Analysis by Country, 2017-2030
  19. Asia Pacific Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  20. Asia Pacific Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  21. Asia Pacific Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  22. Asia Pacific Neurologic Disorders Therapeutics Market Analysis by Country, 2017-2030
  23. MEA Neurologic Disorders Therapeutics Market Absolute $ Opportunity
  24. MEA Neurologic Disorders Therapeutics Market Analysis by Type, 2017-2030
  25. MEA Neurologic Disorders Therapeutics Market Analysis by Application, 2017-2030
  26. MEA Neurologic Disorders Therapeutics Market Analysis by Country, 2017-2030

List of Figures

  1. Global Neurologic Disorders Therapeutics Market Historic Y-o-Y Analysis (%), 2017-2021
  2. Global Neurologic Disorders Therapeutics Market Forecast Y-o-Y Analysis (%), 2022-2030
  3. Global Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  4. Global Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  5. Global Neurologic Disorders Therapeutics Market Share Analysis by Region, 2021 and 2030
  6. North America Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  7. North America Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  8. North America Neurologic Disorders Therapeutics Market Share Analysis by Country, 2021 and 2030
  9. South America Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  10. South America Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  11. South America Neurologic Disorders Therapeutics Market Share Analysis by Country, 2021 and 2030
  12. Europe Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  13. Europe Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  14. Europe Neurologic Disorders Therapeutics Market Share Analysis by Country, 2021 and 2030
  15. Asia Pacific Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  16. Asia Pacific Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  17. Asia Pacific Neurologic Disorders Therapeutics Market Share Analysis by Country, 2021 and 2030
  18. MEA Neurologic Disorders Therapeutics Market Share Analysis by Type, 2021 and 2030
  19. MEA Neurologic Disorders Therapeutics Market Share Analysis by Application, 2021 and 2030
  20. MEA Neurologic Disorders Therapeutics Market Share Analysis by Country, 2021 and 2030
market statsville report image

Want to Review Complete Market Research Report

Request Sample
$3150  $2450 save 23%
$4950  $3850 save 25%
$7680  $5100 save 30%
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Budget constrains? Get in touch with us for special pricing
Request Discount

Phone: +1 (888) 615 4898

Email: sales@regionalresearchreports.com

Chat with Us: Click here to start